Ischemia, reperfusion, and the role of surgery in the treatment of cardiogenic shock secondary to acute myocardial infarction: An interpretative review

Journal of Surgical Research

Volumn 117, Issue 1, 2004, Pages 6-21

  Wernly, Jorge A ^a,b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Acute myocardial infarction; Acute revascularization; Cardiogenic shock; Coronary artery bypass; Hibernation; Myocardial ischemia; Percutaneous coronary interventions; Reperfusion injury; Stunning

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; ASPARTIC ACID; FATTY ACID; FREE RADICAL; GLUCOSE; GLUTAMIC ACID; INOTROPIC AGENT; INSULIN; OXYGEN; POTASSIUM;

ACUTE HEART INFARCTION; AORTA BALLOON; ARTERY OCCLUSION; BLOOD FLOW; CARDIOGENIC SHOCK; CARDIOPLEGIA; CLINICAL TRIAL; COLLATERAL CIRCULATION; COMPLEMENT SYSTEM; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC TEST; DISEASE COURSE; DRUG EFFECT; ELECTROCARDIOGRAM; ENERGY METABOLISM; ENZYME ACTIVATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PRESERVATION; HEART PROTECTION; HUMAN; INOTROPISM; LEUKOPENIA; MOLECULAR DYNAMICS; MUSCLE CELL; NEUTROPHIL; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; REPERFUSION INJURY; REVASCULARIZATION; REVIEW; RISK FACTOR; ST SEGMENT ELEVATION; THROMBOCYTE; VASCULAR DISEASE;

EID: 1542298308     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2003.12.024     Document Type: Article

References (47)

1. Goldberg R., Samad N., Yarzebski J., Gurwitz J., Bigelow C., Gore J. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N. Engl. J. Med. 340:1999;1162.
2. Hochman J., Sleeper L., Webb J., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N. Engl. J. Med. 341:1999;625.
3. Hochman J., Buller C., Sleeper L., et al. Cardiogenic shock complicating acute myocardial infarction - Etiologies, management and outcome A report from the SHOCK Trial registry. J. Am. Coll. Cardiol. 36:2000;1063.
4. Davies C. Revascularization for cardiogenic shock. Q. J. Med. 94:2001;57.
5. Holmes D.R.J., Berger P.B., Hochman J.S., et al. Cardiogenic shock in patients with acute ischaemic syndromes with and without ST segment elevation. Circulation. 100:1999;2067.
6. Jennings R.B., Steenbergen C., Reimer K.A. Myocardial Ischemia and Reperfusion. Shoen F.J., Gimrone M.A. Cardiovascular Pathology Clinicopathologic Correlations and Pathogenetic Mechanisms. 1995;47-80 Williams & Wilkins, Baltimore.
7. Kloner R.A., Bolli R., Marban E., Reinlib L., Braunwald E. and participants. Medical and cellular implications of stunning, hibernation and preconditioning An NHLBI workshop. Circulation. 97:1998;1848.
8. Rao V., Merante F., Weisel R.D., et al. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia. J. Thorac. Cardiovasc. Surg. 116:1998;485.
9. Rao V., Ivanov J., Weisel R., Cohen G., Borger M., Mickle D. Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery. Ann. Thorac. Surg. 71:2001;1925.
10. Apstein C.S. Glucose-insulin-potassium for acute myocardial infarction Remarkable results from a new prospective, randomized trial [editorial]. Circulation. 98:1998;2223.
11. Yellon D.M., Baxter G.F. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction Distant dream or near reality? Heart. 83:2000;381.
12. Heyndrickx G.R., Millard R.W., McRitchie R.J., et al. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J. Clin. Invest. 56:1975;978.
13. Przyklenk K. Pharmacologic treatment of the stunned myocardium The concepts and challenges. Coron. Artery Dis. 12:2001;363-369.
14. Verma S., Fedak P., Weisel R., et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation. 105:2002;2332.
15. Johnson W.D., Kayser K.L., Brenowitz J.B., et al. A randomized controlled trial of allopurinol in coronary bypass surgery. Am. Heart J. 121:1991;20.
16. Flaherty J.T., Pitt B., Gruber J.W., et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation. 89:1994;1982.
17. Woo Y.J., Taylor M.D., Cohen J.E., et al. Ethyl Pyruvate Preserves Cardiac Function and Attenuates Infarct Size Following Prolonged Myocardial Ischemia. American Association for Thoracic Surgery Program, 83rd Annual Meeting. 2003;98-99.
18. Karmazyn M. Mechanisms of protection of the ischemic and reperfused myocardium by sodium-hydrogen exchange inhibition. J. Thromb. Thrombolysis. 8:1999;33.
19. Avkiran M. Rational basis for use of sodium-hydrogen exchange inhibitors I myocardial ischemia. Am. J. Cardiol. 83:1999;10.
20. Theroux P., Chaitman B.R., Danchin N., et al. Guard During Ischemia Against Necrosis (GUARDIAN) Investigators. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations main results of the GUARDIAN trial. Circulation. 102:2000;3032.
21. ATP channel and cardioprotection. Ann. Thorac. Surg. 75:2003;S667.
22. Mentzer R., Birijiniuk V., Shukri K., et al. Adenosine myocardial protection Preliminary results of a phase II clinical trial. Ann. Surg. 229:1999;643.
23. Vinten-Johansen J., Zhao Z., Corvera J.S., et al. Adenosine in myocardial protection in on-pump and off-pump cardiac surgery. Ann. Thorac. Surg. 75:2003;S691.
24. Shiono N., Rao V., Weisel R., et al. L-Arginine protects human heart cells from low-volume anoxia and reoxygenation. Am. J. Physiol. Heart Circ. Physiol. 282:2002;H805.
25. Fath-Ordoubadi F., Beatt K.J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction An overview or randomized placebo-controlled trials. Circulation. 96:1997;1152.
26. Kondo R.P., Apstein C.S., Eberli F.R., Tillotson D.L., Suter T.M. Increased calcium loading and inotropy without greater cell death in hypoxic rat cardiomyocytes. Am. J. Physiol. 275:1998;H2272.
27. Lazar H.L., Chipkin S., Philippides G., Bao Y., Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann. Thorac. Surg. 70:2000;145.
28. Lazar H.L. The insulin cardioplegia trial. J. Thorac. Cardiovascular Surg. 123:2002;842.
29. Lazar H.L., Zhang X., Rivers S., Bernard S., Apstein C.S. Limiting ischemic damage during urgent revascularization using glucose-insulin-potassium solutions. Ann. Thorac. Surg. 60:1995;2227.
30. Lazar H.L., Philippides G., Fitzgerald C., Lancaster D., Shemin R.J., Apstein C. Glucose-insulin-potassium solution enhances after urgent coronary bypass grafting. J. Thorac. Cardiovasc. Surg. 113:1997;354.
31. Allen B.S., Buckberg G.D., Fontan F.M., et al. Superiority of controlled surgical reperfusion versus percutaneous transluminal coronary angioplasty acute coronary occlusion. J. Thorac. Cardiovasc. Surg. 105:1993;864.
32. Sawa Y., Matsuda H. Myocardial protection with leukocyte depletion in cardiac surgery. Semin. Thorac. Cardiovasc. Surg. 13:2001;73.
33. Faxon D.P., Gibbons R.J., Chronos N.A., et al. The effect of a CD11/CD18 inhibitor (Hu23F2G) on infarct size following direct angioplasty The HALT MI study. Circulation. 100:1999;1.
34. Bates E.R., Stomel R.J., Hochman J.S., Ohman E.M. The use of intraaortic balloon couterpulsation an adjunct to reperfusion therapy in cardiogenic shock. Int. J. Cardiol. 65:1998;S37.
35. Hasdai D., Holmes D.R.J., Topol E.J., et al. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. Eur. Heart J. 20:1999;128.
36. White H.D., Van de Werf F.J. Thrombolysis for acute myocardial infarction. Circulation. 97:1998;1632.
37. Gurbel P.A., Anderson R.D., MacCord C.S., et al. Arterial diastolic pressure augmentation by intraaortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy. Circulation. 89:1994;361.
38. Prewitt R.M., Gu S., Garber P.J., et al. Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator. J. Am. Coll. Cardiol. 20:1992;1626.
39. Berger P.B., Tuttle R.H., Holmes D.R., et al. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization. Results from GUSTO-1. Circulation. 99:1999;873.
40. Edep M.E., Brown D.L. Effect of early revascularization on mortality from cardiogenic shock complicating acute myocardial infarction. Am. J. Cardiol. 85:2000;1185.
41. Gitt A.K., Schiele R., Seidl K., et al. Influence of recanalization therapy on prognosis of cardiogenic shock in acute myocardial infarction in unselected patients of the MITRA study. J. Am. Coll. Cardiol. 33:1999;375A.
42. Carnendran L., Gurunathan R., Webb J., et al. Trends in cardiogenic shock Report from the SHOCK trial registry. J. Am. Coll. Cardiol. 33:1999;366A.
43. Hochman J., Sleeper L., White H., et al. One-year survival following early revascularization for cardiogenic shock. JAMA. 285:2001;190.
44. Urban P., Stauffer J.C., Bleed D., et al. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur. Heart J. 20:1999;1030.
45. Ryan T. Early revascularization in cardiogenic shock - A positive view of a negative trial. N. Engl. J. Med. 341:1999;687.
46. Ryan T., Antman E., Brooks N., et al. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on management of acute myocardial infarction). Circulation. 100:1999;1016.
47. Gross G.J., Kersten J.R., Warltier D.C. Mechanisms of postischemic contractile dysfunction. Ann. Thorac. Surg. 68:1999;1898.